日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pathological outcomes in women with cervical adenocarcinoma In Situ treated by conisation or conisation followed by hysterectomy

采用锥切术或锥切术后行子宫切除术治疗原位宫颈腺癌女性患者的病理结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1692524
Li, Lan Ying; Song, Da Long; Sun, Xiao Ying; Li, Zhi Gang; You, Ke Li
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Burnout in nursing during the COVID-19 pandemic: A bibliometric analysis of global research (2020-2023)

新冠疫情期间护理人员的职业倦怠：全球研究的文献计量分析（2020-2023）

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000046125
Lu, Ya-Xi; Wan, Da-Long
微生物学
新冠
发表日期：2026
文献求助 收藏

Long-term and short-term outcomes of curative-intent resection for elderly and younger patients with gallbladder carcinoma: a multicentre propensity score-matched cohort study

老年和年轻胆囊癌患者根治性切除术的长期和短期疗效：一项多中心倾向评分匹配队列研究

期刊:
影响因子:
doi:10.1136/egastro-2025-100323
Pan, Yu; Ye, Chun-Yue; Zhao, Peng; Dai, Hai-Su; Jiang, Yan; Huang, Yu-Cheng; Chen, Cheng; Luo, Yu-Le; Ding, Jun-Jie; Ding, Rui; Yue, Ping; Huang, Fan; Yu, Chao; Wu, Zhao-Ping; Chen, Wei; Zhou, Jin-Xue; Guo, Wei; Yin, Da-Long; Chen, Wei; Zhu, Yi; Bai, Jie; Zhang, Yan-Qi; Zhang, Dong; Wang, Ya-Yun; Yang, Yan-Ling; Liu, Zhi-Peng; Guo, Rui; Chen, Zhi-Yu
肿瘤
肿瘤免疫
胆囊癌
发表日期：2026
文献求助 收藏

Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002)

一项多中心回顾性研究（GUIDANCE002）表明，新辅助经动脉化疗栓塞联合酪氨酸激酶和免疫检查点抑制剂可提高可切除肝细胞癌患者的生存率。

期刊:
影响因子:
doi:10.1038/s43856-025-01303-w
Yang, Da-Long; Qin, Chuang; Peng, Ning; Liu, Shao-Ping; Yu, Ya-Qun; Nong, Jun-Liang; Zeng, Fan-Jian; Su, Ze; Yang, Yong-Yu; Yang, Fu-Quan; Li, Mian-Jing; Wu, Ming-Song; Wang, Xue-Yao; Liang, Yong-Rong; Li, Fu-Xin; Chen, Shu-Chang; Lai, Yong-Cheng; Pang, Qing-Qing; Zhong, Teng-Meng; Yan, Yi-He; Zhang, Ying-Yu; Ye, Lin; Dong, Xiao-Feng; Li, Wen-Feng; Liu, Jie; Yao, Hong-Bing; Wu, Pei-Sheng; Mao, Xian-Shuang; Ou, Jun-Jie; Chen, Yao-Zhi; Wang, Guo-Dong; Chen, Kang; Deng, Zhu-Jian; Su, Jia-Yong; Qiu, Guo-Gao; Liu, Zhi-Dong; Wang, Jin-Min; Zhang, Yi; Liang, Xiu-Mei; Xiang, Bang-De; Ma, Liang; Zhong, Jian-Hong
肿瘤
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma

DOCK4表达升高与透明细胞肾细胞癌的良好预后和免疫浸润相关

期刊:
影响因子:
doi:10.1080/07853890.2026.2642533
He, Da-Long; Zhu, Fang-Fang; Wang, Jia; Zhu, Su-Wei; Hou, Shao-Shuai
肿瘤
DOCK4
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

ROS regulates circadian rhythms by modulating Ezh2 interactions with clock proteins.

ROS 通过调节 Ezh2 与时钟蛋白的相互作用来调节昼夜节律

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2025.103526
Zhang Hao-Yi, Li Ke-Yun, Wang Yi-Li, Wei Chun-Jiao, Gao Yu-Xuan, Ren-Zhou, Zhong Ying-Bin, Yin Zong-Jun, Ren Da-Long
免疫/内分泌
发表日期：2025
文献求助 收藏

Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study

肝细胞癌切除术后复发高风险患者辅助免疫检查点抑制剂治疗持续时间：一项前瞻性多中心队列研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000542954
Su, Jia-Yong; Liu, Shao-Ping; Xu, Xiao-Ling; Ou, Jun-Jie; Ye, Po-Hua; Zhao, Bin-Tong; Chen, Jia-Song; Luo, Qiu-Mei; Liu, Jin-Rong; Tang, Fei-Min; Li, Jian-Rong; Yang, Da-Long; Deng, Zhu-Jian; Pan, Li-Xin; Li, Yao-Jie; Li, Le; Qin, Zhen-Ming; Liang, Xiu-Mei; Ma, Yi-Li; Ma, Liang; Zhong, Jian-Hong
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study

不可切除肝细胞癌转化治疗后完全或部分缓解行肝切除术的生存获益（GUIDANCE003）：一项多中心研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000546052
Yang, Da-Long; Peng, Ning; Nong, Jun-Liang; Chen, Kang; Su, Ze; Yu, Ya-Qun; Ye, Lin; Zeng, Fan-Jian; Liu, Shao-Ping; Yan, Yi-He; Wang, Xue-Yao; Yao, Hong-Bing; Yang, Fu-Quan; Li, Wen-Feng; Qin, Chuang; Wu, Ming-Song; Yang, Yong-Yu; Dong, Xiao-Feng; Li, Mian-Jing; Liu, Jie; Liang, Yong-Rong; Wu, Pei-Sheng; Zhong, Teng-Meng; Lai, Yong-Cheng; Chen, Yao-Zhi; Pang, Qing-Qing; Wang, Guo-Dong; Li, Fu-Xin; Mao, Xian-Shuang; Chen, Shu-Chang; Ou, Jun-Jie; Huo, Rong-Rui; Liang, Xiu-Mei; Xiang, Bang-De; Ma, Liang; Zhong, Jian-Hong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE006)

PD-1抑制剂联合疗法治疗不可切除肝细胞癌后临床完全缓解的预后价值（GUIDANCE006）

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000549844
Ma, Liang; Yang, Da-Long; Zhong, Teng-Meng; Pang, Qing-Qing; Luo, Min; Li, Wen-Feng; Yan, Yi-He; Chen, Kang; Wang, Guo-Dong; Yang, Fu-Quan; Lai, Yong-Cheng; Wu, Ming-Song; Dong, Xiao-Feng; Yang, Yong-Yu; Peng, Ning; Nong, Jun-Liang; Su, Ze; Yu, Ya-Qun; Ye, Lin; Zeng, Fan-Jian; Liu, Shao-Ping; Wang, Xue-Yao; Yao, Hong-Bing; Qin, Chuang; Li, Mian-Jing; Liu, Jie; Liang, Yong-Rong; Wu, Pei-Sheng; Li, Fu-Xin; Chen, Shu-Chang; Lu, Si-Cong; Li, Zhi-Cheng; Liu, Zhen; Guo, Ping-Ping; Pan, Li-Xin; Zhong, Jian-Hong
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Author Correction: Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells

作者更正：选择性TRF2抑制剂FKB04的发现可诱导肝癌细胞端粒缩短和衰老

期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-024-01370-0
Qiu, Yin-da; Yan, Qi; Wang, Yi; Ye, Yan-Fei; Wang, Yan; Wang, Meng-Ying; Wang, Pei-Pei; Zhang, Shu-Yuan; Wang, Da-Long; Yan, Hao; Ruan, Jing; Zhao, Yun-Jie; Huang, Le-Hao; Cho, Namki; Wang, Kun; Zheng, Xiao-Hui; Liu, Zhi-Guo
肝癌
衰老
肿瘤
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏